LGMN and Alzheimer disease: Interestingly, AEP is dysregulated and activated during aging, and AEP activity is increased in regions of degeneration in AD human brain and mouse models suggesting that PGRN processing and granulin F production may be altered in other neurodegenerative diseases as well [49].